Literature DB >> 15639794

Does beta-amyloid plaque formation cause structural injury to neuronal processes?

Adele Woodhouse1, Adrian K West, Jyoti A Chuckowree, James C Vickers, Tracey C Dickson.   

Abstract

The precise role of beta-amyloid plaque formation in the cascade of brain cell changes that lead to neurodegeneration and dementia in Alzheimer's disease has been unclear. Studies have indicated that neuronal processes surrounding and within plaques undergo a series of biochemical and morphological alterations. Morphological alterations include reactive, degenerative and sprouting-related 'dystrophic' neuritic structures, derived principally from axons, which involve specific changes in cytoskeletal proteins such as tau and NF triplet proteins. More compact and fibrous plaques are associated with more extensive neuritic pathology than non-fibrillar, diffuse beta-amyloid deposits. Cortical apical dendritic processes are either 'clipped' by plaque formation or are bent around more compact plaques. Examination of cases of 'pathological' brain ageing, which may represent a preclinical form of Alzheimer's disease, demonstrated that the earliest neuritic pathology associated with plaques was similar to the reactive changes that follow structural injury to axons. In vivo and in vitro experimental models of structural injury to axons produce identical reactive changes that subsequently lead to an attempt at regenerative sprouting by damaged axons. Thus, beta-amyloid plaque formation may cause structural injury to axons that is subsequently followed by an aberrant sprouting response that presages neurodegeneration and dementia. Identification of the key neuronal alterations underlying the pathology of Alzheimer's disease may provide new avenues for therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15639794     DOI: 10.1007/BF03033772

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  100 in total

1.  Cytoskeletal and morphological alterations underlying axonal sprouting after localized transection of cortical neuron axons in vitro.

Authors:  Jyoti A Chuckowree; James C Vickers
Journal:  J Neurosci       Date:  2003-05-01       Impact factor: 6.167

2.  Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.

Authors:  R D Terry; E Masliah; D P Salmon; N Butters; R DeTeresa; R Hill; L A Hansen; R Katzman
Journal:  Ann Neurol       Date:  1991-10       Impact factor: 10.422

3.  Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3 beta and cyclin-dependent kinase 5, a component of TPK II.

Authors:  H Yamaguchi; K Ishiguro; T Uchida; A Takashima; C A Lemere; K Imahori
Journal:  Acta Neuropathol       Date:  1996-09       Impact factor: 17.088

Review 4.  Copernicus revisited: amyloid beta in Alzheimer's disease.

Authors:  J Joseph; B Shukitt-Hale; N A Denisova; A Martin; G Perry; M A Smith
Journal:  Neurobiol Aging       Date:  2001 Jan-Feb       Impact factor: 4.673

Review 5.  Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide.

Authors:  C Haass; D J Selkoe
Journal:  Cell       Date:  1993-12-17       Impact factor: 41.582

6.  Microtubule-affinity regulating kinase (MARK) is tightly associated with neurofibrillary tangles in Alzheimer brain: a fluorescence resonance energy transfer study.

Authors:  J Y Chin; R B Knowles; A Schneider; G Drewes; E M Mandelkow; B T Hyman
Journal:  J Neuropathol Exp Neurol       Date:  2000-11       Impact factor: 3.685

Review 7.  Biochemistry of Alzheimer's disease amyloid plaques.

Authors:  P E Fraser; L Lévesque; D R McLachlan
Journal:  Clin Biochem       Date:  1993-10       Impact factor: 3.281

Review 8.  Role of cdk5 in the pathogenesis of Alzheimer's disease.

Authors:  Lit-Fui Lau; Michael K Ahlijanian
Journal:  Neurosignals       Date:  2003 Sep-Oct

9.  Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease.

Authors:  L M Bierer; P R Hof; D P Purohit; L Carlin; J Schmeidler; K L Davis; D P Perl
Journal:  Arch Neurol       Date:  1995-01

10.  Amyloid-beta antibody treatment leads to rapid normalization of plaque-induced neuritic alterations.

Authors:  Julianne A Lombardo; Edward A Stern; Megan E McLellan; Stephen T Kajdasz; Gregory A Hickey; Brian J Bacskai; Bradley T Hyman
Journal:  J Neurosci       Date:  2003-11-26       Impact factor: 6.167

View more
  10 in total

Review 1.  Biochemical, cellular and behavioural aspects of neurodegeneration: the view from down under.

Authors:  David H Small
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

Review 2.  The intersection of amyloid beta and tau at synapses in Alzheimer's disease.

Authors:  Tara L Spires-Jones; Bradley T Hyman
Journal:  Neuron       Date:  2014-05-21       Impact factor: 17.173

Review 3.  Neurotoxins and neurotoxicity mechanisms. An overview.

Authors:  Juan Segura-Aguilar; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

Review 4.  Tau Oligomers: The Toxic Player at Synapses in Alzheimer's Disease.

Authors:  Marcos J Guerrero-Muñoz; Julia Gerson; Diana L Castillo-Carranza
Journal:  Front Cell Neurosci       Date:  2015-12-02       Impact factor: 5.505

5.  Neurites containing the neurofilament-triplet proteins are selectively vulnerable to cytoskeletal pathology in Alzheimer's disease and transgenic mouse models.

Authors:  Stanislaw Mitew; Matthew T K Kirkcaldie; Tracey C Dickson; James C Vickers
Journal:  Front Neuroanat       Date:  2013-09-26       Impact factor: 3.856

6.  Up-regulation of Synaptotagmin IV within amyloid plaque-associated dystrophic neurons in Tg2576 mouse model of Alzheimer's disease.

Authors:  Larisa Tratnjek; Marko Zivin; Gordana Glavan
Journal:  Croat Med J       Date:  2013-10-28       Impact factor: 1.351

7.  Short-term fish oil supplementation applied in presymptomatic stage of Alzheimer's disease enhances microglial/macrophage barrier and prevents neuritic dystrophy in parietal cortex of 5xFAD mouse model.

Authors:  Milena Jović; Nataša Lončarević-Vasiljković; Sanja Ivković; Jelena Dinić; Desanka Milanović; Berislav Zlokovic; Selma Kanazir
Journal:  PLoS One       Date:  2019-05-16       Impact factor: 3.752

8.  Brain-wide Cas9-mediated cleavage of a gene causing familial Alzheimer's disease alleviates amyloid-related pathologies in mice.

Authors:  Yangyang Duan; Tao Ye; Zhe Qu; Yuewen Chen; Abigail Miranda; Xiaopu Zhou; Ka-Chun Lok; Yu Chen; Amy K Y Fu; Viviana Gradinaru; Nancy Y Ip
Journal:  Nat Biomed Eng       Date:  2021-07-26       Impact factor: 29.234

Review 9.  Axonal Degeneration in AD: The Contribution of Aβ and Tau.

Authors:  Natalia Salvadores; Cristian Gerónimo-Olvera; Felipe A Court
Journal:  Front Aging Neurosci       Date:  2020-10-15       Impact factor: 5.750

Review 10.  Current Understanding of the Physiopathology, Diagnosis and Therapeutic Approach to Alzheimer's Disease.

Authors:  Victoria García-Morales; Anabel González-Acedo; Lucía Melguizo-Rodríguez; Teresa Pardo-Moreno; Víctor Javier Costela-Ruiz; María Montiel-Troya; Juan José Ramos-Rodríguez
Journal:  Biomedicines       Date:  2021-12-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.